A randomized comparative effectiveness trial for preventing type 2 diabetes

American Journal of Public Health

Volumn 105, Issue 11, 2015, Pages 2328-2334

  Ackermann, Ronald T ^a   Liss, David T ^a   Finch, Emily A ^a   Schmidt, Karen K ^b   Hays, Laura M ^c   Marrero, David G ^b   Saha, Chandan ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY SCHOOL OF NURSING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE BLOOD LEVEL;

ADULT; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; COUNSELING; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH BEHAVIOR; HUMAN; INDIANA; LIFESTYLE; MALE; MIDDLE AGED; OBESITY; ORGANIZATION AND MANAGEMENT; OVERWEIGHT; POVERTY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; WEIGHT LOSS PROGRAM; WEIGHT REDUCTION;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; COUNSELING; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH BEHAVIOR; HUMANS; INDIANA; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; POVERTY; SINGLE-BLIND METHOD; WEIGHT LOSS; WEIGHT REDUCTION PROGRAMS;

EID: 84943737225     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2015.302641     Document Type: Article

References (36)

1. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010;303(3):235-241.
2. US Census Bureau. Population estimates. 2009. Available at: http://www. census. gov/popest/national/ asrh. Accessed March 26, 2014.
3. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
4. McTigue KM, Harris R, Hemphill B, et al. Screening and interventions for obesity in adults: summary of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2003;139(11):933-949.
5. Wing RR, Hamman RF, Bray GA, et al. Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obes Res. 2004;12(9): 1426-1434.
6. Hernan WH, Brandle M, Zhang P, et al. Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care. 2003;26(1):36-47.
7. Garfield SA, Malozowski S, Chin MH, et al. Considerations for diabetes translational research in real-world settings. Diabetes Care. 2003;26(9):2670-2674.
8. Ali MK, Echouffo-Tcheugui J, Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program? Health Aff (Millwood). 2012;31(1):67-75.
9. Hamman RF, Wing RR, Edelstein SL, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006;29(9):2102-2107.
10. Ackermann RT, Finch EA, Schmidt KK, et al. Rationale, design, and baseline characteristics of a community-based comparative effectiveness trial to prevent type 2 diabetes in economically disadvantaged adults: The RAPID Study. Contemp Clin Trials. 2014; 37(1):1-9.
11. National Diabetes Education Program. Diabetes Prevention. Bethesda, MD: National Institutes of Health, the Centers for Disease Control and Prevention, Department of Health and Human Services; 2010.
12. Ackermann RT, Marrero DG. Adapting the Diabetes Prevention Program lifestyle intervention for delivery in the community: The YMCA model. Diabetes Educ. 2007;33(1):69, 74-75, 77-78.
13. Diabetes Prevention Program. DPP lifestyle materials for sessions 1-16-lifestyle coach materials and optional participant handouts. Available at: https:// dppos. bsc. gwu. edu/web/dppos/during-core. Accessed March 25, 2015.
14. Diabetes Prevention Program. DPP lifestyle materials for beyond session 16-lifestyle coach materials and participant handouts. Available at: https://dppos. bsc. gwu. edu/web/dppos/after-core. Accessed March 25, 2015.
15. Ackermann RT, Finch EA, Caffrey HM, Lipscomb ER, Hays LM, Saha C. Long-term effects of a community-based lifestyle intervention to prevent type 2 diabetes: The DEPLOY extension pilot study. Chronic Illn. 2011;7(4):279-290.
16. Finch EA, Kelly MS, Marrero DG, Ackermann RT. Training YMCA wellness instructors to deliver an adapted version of the Diabetes Prevention Program lifestyle intervention. Diabetes Educ. 2009;35(2):224-228, 232.
17. John WG, Edwards R, Price CP. Laboratory evaluation of the DCA 2000 clinic HbA1c immunoassay analyser. Ann Clin Biochem. 1994;31(pt 4):367-370.
18. Tamborlane WV, Kollman C, Steffes MW, et al. Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study. Pediatr Diabetes. 2005;6(1):13-16.
19. Santee J. Accuracy and precision of the Cholestech LDX System in monitoring blood lipid levels. Am J Health Syst Pharm. 2002;59(18):1774-1779.
20. Bard RL, Kaminsky LA, Whaley MH, Zajakowski S. Evaluation of lipid profile measurements obtained from the Cholestech L. D. X analyzer. J Cardiopulm Rehabil. 1997;17(6):413-418.
21. Marchenko Y. Multiple-imputation analysis using Stata's mi command. Available at: http://www. stata. com/ meeting/boston10/boston10-marchenko. pdf. Accessed July 24, 2014.
22. Rubin DB. Multiple imputation after 18+ years. J Am Stat Assoc. 1996;91(434):473-489.
23. Pavey TG, Anokye N, Taylor AH, et al. The clinical effectiveness and cost-effectiveness of exercise referral schemes: A systematic review and economic evaluation. Health Technol Assess. 2011;15(44):i-xii, 1-254.
24. Waterman MR, Wiecha JM, Manne J, Tringale SM, Costa E, Wiecha JL. Utilization of a free fitness centerbased exercise referral program among women with chronic disease risk factors. J Community Health. 2014; 39(6):1179-1185.
25. Angrist JD, Imbens GW, Rubin DB. Identification of causal effects using instrumental variables. J Am Stat Assoc. 1996;91(434):444-44552.
26. Sussman JB, Hayward RA. An IV for the RCT: using instrumental variables to adjust for treatment contamination in randomised controlled trials. BMJ. 2010;340:c2073.
27. Venditti EM, Kramer MK. Necessary components for lifestyle modification interventions to reduce diabetes risk. Curr Diab Rep. 2012;12(2):138-146.
28. Zhou XH, Li SM. ITT analysis of randomized encouragement design studies with missing data. Stat Med. 2006;25(16):2737-2761.
29. Schoenbaum M, Unützer J, McCaffrey D, Duan N, Sherbourne C, Wells KB. The effects of primary care depression treatment on patients' clinical status and employment. Health Serv Res. 2002;37(5):1145-1158.
30. Blackwell CS, Foster KA, Isom S, et al. Healthy Living Partnerships to Prevent Diabetes: recruitment and baseline characteristics. Contemp Clin Trials. 2011; 32(1):40-49.
31. Katula JA, Vitolins MZ, Rosenberger EL, et al. Healthy Living Partnerships to Prevent Diabetes (HELP PD): design and methods. Contemp Clin Trials. 2010; 31(1):71-81.
32. Katula JA, Vitolins MZ, Rosenberger EL, et al. Oneyear results of a community-based translation of the Diabetes Prevention Program: Healthy-Living Partnerships to Prevent Diabetes (HELP PD) Project. Diabetes Care. 2011;34(7):1451-1457. [Erratum in Diabetes Care. 2012;35(2):455].
33. Diabetes Prevention Program Outcomes Study Research Group; Orchard TJ, Temprosa M, et al. Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: A report from the DPP Outcomes Study. Diabet Med. 2013;30(1):46-55.
34. Look AHEAD Research Group; Pi-Sunyer X, Blackburn G, et al. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care. 2007;30(6):1374-1383.
35. Ratner R, Goldberg R, Haffner S, et al. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care. 2005;28(4):888-894.
36. Look AHEAD Research Group; Wing RR, Bolin P, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369 (2):145-154. [Erratum in N Engl J Med. 2014;370 (19):1866].